REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Triyasa Nagamas Farma (Indonesia)

Main Activities: Medicinal and Botanical Manufacturing
Full name: PT Triyasa Nagamas Farma Profile Updated: November 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Triyasa Nagamas Farma is a pharmaceutical company based in Indonesia. It specializes in the production of oral, injectable, and implant contraceptives, over the counter (OTC) products, and other consumer products in a Good Manufacturing Practice (GMP) and ISO-qualified environment. The company uses modern production and laboratory equipment. The company offers a range of oral, injectable, and implant contraceptives, as well as OTC products and other consumer products.

Headquarters
Kawasan Industri Pulogadung Jl. Rawa Udang No. 75
East Jakarta; Jakarta; Postal Code: 13920

Contact Details: Purchase the PT Triyasa Nagamas Farma report to view the information.

Website: http://www.triyasa.com

Basic Information
Total Employees:
Purchase the PT Triyasa Nagamas Farma report to view the information.
Registered Capital:
Purchase the PT Triyasa Nagamas Farma report to view the information.
Financial Auditors:
Purchase the PT Triyasa Nagamas Farma report to view the information.
Incorporation Date:
February 11, 1988
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Triyasa Nagamas Farma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
11.24%
Total operating revenue
11.24%
Total Assets
13.92%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?